Opening Possibilities, Illuminating Potentials
Islandwide Free Delivery. 2-5 Days.

Cart

Your Cart is Empty

Back To Shop
Contact Us 0764980321

Bad Blood: Secrets and Lies in a Silicon Valley Startup

Rs. 2,490.00

John Carreyrou

 

  • WINNER OF THE FINANCIAL TIMES/MCKINSEY BUSINESS BOOK OF THE YEAR AWARD 2018
  • Los Angeles Times Book Prize Nominee for Current Interest (2018)
  • Goodreads Choice Award Nominee for Nonfiction (2018)

 

I couldn’t put down this thriller with a tragic ending . . . a book so compelling that I couldn’t turn away . . . This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion — Bill Gates, ‘5 books I loved in 2018’

 

A dazzling story of deception in Silicon Valley . . . You will not be able to put this book down. ― Washington Post

 

Carreyrou tells the story virtually to perfection . . . Bad Blood reads like a West Coast version of All the President’s Men. ― New York Times Book Review

 

Riveting . . . a blistering critique of Silicon Valley . . . The real heroes, though, are his sources: the young scientists who worked at the company and risked their reputations and careers by voicing their concerns. Were it not for their courage, Theranos might still be testing blood today — David Crow ― Financial Times

 

In this Silicon Valley drama, he opens his reporter’s notebook to deliver a tale of corporate fraud and legal browbeating that reads like a crime thriller. — The 10 Best Nonfiction Books of 2018 ― TIME

 

A beautifully controlled narrative that challenges the gold-rush mentality of Silicon Valley. — Lionel Barber, Editor of the FT, ‘Books of the Year 2018’ ― Financial Times

Only 2 left in stock

The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work.

For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company’s value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.

 

About the Author

John Carreyrou is a member of the Wall Street Journal’s investigative reporting team. He joined the Journal in 1999 and has been based in Brussels, Paris, and New York for the paper, winning two Pulitzer prizes.

John has covered a number of topics during his career, ranging from Islamist terrorism when he was on assignment in Europe to the pharmaceutical industry and the U.S. healthcare system. His reporting on corruption in the field of spine surgery led to long prison terms for a California hospital owner and a Michigan neurosurgeon. His reporting on Theranos, a blood-testing startup founded by Elizabeth Holmes, was recognized with a George Polk award, and is chronicled in his book Bad Blood: Secrets and Lies in a Silicon Valley Startup.

Born in New York and raised in Paris, he currently resides in Brooklyn with his wife and three children.

 

  • Paperback ‏ : ‎ 320 pages

Cart

Your Cart is Empty

Back To Shop